Ashish Saharia
Overview
Explore the profile of Ashish Saharia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1004
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Semaan S, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Proc
. 2025 Feb;
57(2):255-263.
PMID: 39939239
Background: Cholangiocarcinoma (CCA) has rising incidence and mortality rates. Outcomes from combination systemic, loco-regional therapy (LRT) and liver transplantation (LT) are improving, but more granular data are needed to inform...
2.
Soliman N, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Direct
. 2025 Feb;
11(3):e1760.
PMID: 39936132
Background: Perihilar cholangiocarcinoma (phCCA) has excellent outcomes following liver transplantation (LT). Neoadjuvant radiation-based locoregional therapy is standard-of-care. Gemcitabine and cisplatin (gem/cis) combination systemic therapies have improved outcomes in advanced settings,...
3.
Hassanain H, Connor A, Brombosz E, Patel K, Elaileh A, Basra T, et al.
Transplant Direct
. 2025 Jan;
11(2):e1746.
PMID: 39866680
Background: Hepatocellular carcinoma (HCC) has a rising incidence and mortality in North America. Liver transplantation (LT) with adjunctive therapies offers excellent outcomes. However, HCC recurrences are associated with high mortality....
4.
Brombosz E, Hobeika M, Kodali S, Connor A, Saharia A, Mobley C, et al.
Transplant Proc
. 2024 Dec;
56(10):2203-2212.
PMID: 39617682
Background: The deceased donor shortage in the United States has led to increased utilization extended criteria donor (ECD) liver grafts. Centers often utilize ECD grafts in patients with low Model...
5.
Brombosz E, Moore L, Mobley C, Kodali S, Saharia A, Hobeika M, et al.
Front Transplant
. 2024 Jul;
2:1181770.
PMID: 38993927
Background: Liver retransplantation (reLT) has historically had inferior survival relative to primary liver transplant (LT). To improve outcomes after reLT, researchers have identified factors predicting overall (OS) and/or graft survival...
6.
Abdelrahim M, Esmail A, Divatia M, Xu J, Kodali S, Victor D, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892779
Hepatocellular carcinoma (HCC) is widely recognized as the predominant type of primary liver malignancy. Orthotopic liver transplantation (OLT) has emerged as a highly effective treatment option for unresectable HCC. Immunotherapies...
7.
Kodali S, Mobley C, Brombosz E, Lopez A, Graves R, Ontiveros J, et al.
Transpl Immunol
. 2024 Mar;
84:102034.
PMID: 38499048
Background: Although Hispanic patients have high rates of end-stage liver disease and liver cancer, for which liver transplantation (LT) offers the best long-term outcomes, they are less likely to receive...
8.
Adelman M, Connor A, Hsu E, Saharia A, Mobley C, Victor 3rd D, et al.
JAC Antimicrob Resist
. 2024 Jan;
6(1):dlad158.
PMID: 38213312
Background: Solid organ transplant (SOT) recipients are at risk of bloodstream infections (BSIs) with MDR organisms (MDROs). Objectives: To describe the epidemiology of BSI in the year after several types...
9.
Soliman N, Saharia A, Abdelrahim M, Connor A
Curr Opin Organ Transplant
. 2023 Dec;
29(1):10-22.
PMID: 38038621
Purpose Of Review: The purpose of this review is to both summarize the current knowledge of hepatocellular carcinoma molecular biology and to suggest a framework in which to prospectively translate...
10.
Abdelrahim M, Esmail A, Abudayyeh A, Murakami N, Victor D, Kodali S, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001597
Transplant oncology is an emerging concept of cancer treatment with a promising prospective outcome. The applications of oncology, transplant medicine, and surgery are the core of transplant oncology to improve...